autoimmune disease

Eight Months After First FDA Approval, Aurinia Picks Up Two More Candidates
BioSpace
Tue, 08/17/21 - 10:40 pm
Aurinia Pharmaceuticals
autoimmune disease
Thunderbolt Pharma
M&A
Moderna takes first autoimmune therapeutic candidate into the clinic
Biopharma Reporter
Mon, 08/2/21 - 10:59 am
Moderna Therapeutics
mRNA-6231
autoimmune disease
clinical trials
New JV from upstart biotechs Pyxis, Alloy aims for rapid drug development in cancer, autoimmune diseases
Fierce Biotech
Tue, 05/25/21 - 11:12 am
Pyxis Oncology
Alloy Therapeutics
Kyma Therapeutics
cancer
autoimmune disease
antibody-drug conjugate
Another 5 years of dominance: Oncology, immunology will extend their lead as pharma's top fields through 2025
Fierce Pharma
Fri, 05/7/21 - 10:39 am
biosimilars
oncology
immunology
autoimmune disease
cancer
Biotech startup Repertoire adds $189M to expand array of immune medicines
MedCity News
Tue, 04/13/21 - 10:21 am
Repertoire Immune Medicines
autoimmune disease
infectious diseases
Genmab could spin out autoimmune disease unit, says CEO
Pharmaforum
Wed, 04/7/21 - 10:22 am
Genmab
autoimmune disease
spinoffs
Lilly wagers almost $1B on Rigel's drugs for immune and nervous systems
BioPharma Dive
Thu, 02/18/21 - 10:05 pm
Eli Lilly
Rigel Pharmaceuticals
autoimmune disease
inflammatory disease
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Fierce Biotech
Thu, 02/4/21 - 10:36 am
Roche
earnings
cancer
autoimmune disease
drug development
Horizon inks $3B deal to buy AstraZeneca spinout Viela for autoimmune drugs
Fierce Biotech
Mon, 02/1/21 - 10:33 am
Horizon Therapeutics
AstraZeneca
Viela Bio
autoimmune disease
R&D
M&A
Amgen ponies up $240M for Michigan discovery outfit's dendritic cell-based molecules for autoimmune disorders
Endpoints
Wed, 01/13/21 - 10:34 am
Amgen
autoimmune disease
Evoq Therapeutics
Pandion unveils new data to back up strategy of activating PD-1 to treat autoimmune diseases
Fierce Biotech
Mon, 11/2/20 - 10:34 am
Pandion
autoimmune disease
FOCIS
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Motley Fool
Sun, 08/16/20 - 10:44 pm
Pfizer
biosimilars
Humira
Inflectra
Remsima
Remicade
autoimmune disease
JNJ
Pandion Raises $80 Million Series B to Advance Autoimmune Therapies
BioSpace
Wed, 04/1/20 - 10:14 am
Pandion Therapeutics
autoimmune disease
Lilly pays Sitryx $50M upfront for preclinical autoimmune assets
Fierce Biotech
Tue, 03/31/20 - 11:06 am
Eli Lilly
Sitryx
autoimmune disease
Thymus atlas could spark new treatments for cancer, autoimmune disease
Fierce Biotech
Thu, 02/20/20 - 11:34 pm
thymus
autoimmune disease
cancer
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer
Xconomy
Fri, 02/7/20 - 10:39 am
Sonoma Biosciences
cell therapy
autoimmune disease
5 years of biosimilars in the US: what have we learned?
Pharmaforum
Wed, 01/29/20 - 10:23 am
biosimilars
cancer
autoimmune disease
Adrangi mounts short attack on 'worthless' drugs of Sanofi ally
Fierce Biotech
Tue, 01/28/20 - 11:07 am
Principia Biopharma
Sanofi
autoimmune disease
Kerrisdale Capital
2 Biotechs Battling Immune Diseases
Motley Fool
Sun, 01/19/20 - 07:41 pm
Rigel Pharmaceuticals
Momenta Pharmaceuticals
autoimmune disease
biologics
small molecule drugs
After closing one of China's biggest-ever raises, I-Mab Biopharma nabs $104M Nasdaq IPO
Fierce Biotech
Fri, 01/17/20 - 12:08 pm
IPOs
China
NASDAQ
I-Mab Biopharma
autoimmune disease
cancer

Pages